Back to Awarded Treatment Trials


Awarded Trial: 14T-006

Grant ID

14T-006

Illness

Schizophrenia

Primary Drug/Intervention

Minocycline or Doxycycline

Primary Dosage

100 mg B.I.D.

Secondary Drug Intervention

antipsychotic drug treatment

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Opler

Sample Size

210

Duration of Study Period for Each Subject

70 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Mark Opler

Degree

PhD, MPH

Center

N/A

Institution

Prophase, Inc.

Address

N/A

City or Town

N/A

State or Province

N/A

Zip or Postal Code

N/A

Country

USA

Email Address

mark.opler@prophase.com